Company Cash Funds: enGene Holdings Inc (ENGN)

Official company branding of engene.com (ENGN)

The cash volume dynamics on this GURU.Markets chart, where the 0.27 value expresses the metric level, correlate with revenues from the creation of non-viral bladder cancer therapy methodologies for enGene Holdings Inc. (ENGN). A team of immunologists is developing innovative gene delivery platforms based on an academic approach. However, the narrow specialization of the pipeline creates binary risks, tying business stability to clinical test results.

ENGN - enGene Corp Company Cash Reserve over the range 02/21/2024 - 11/21/2026

Financial and market metric breakdowns for enGene Holdings Inc (ENGN)

- company stock exchange capitalization indicators:
Analysis of all company metrics:ENGN enGene Holdings Inc.
Brand item of enGene

Developing local gene therapy methods to combat oncology requires significant R&D capital expenditures. This metric aggregates all available liquid capital, determining the issuer's ability to fund research without external borrowing. Analyzing the cash-on-hand indicator allows for tracking the burn rate during clinical trial periods. A stable cash balance confirms the financial stability of enGene Holdings Inc. (ENGN) and investor confidence in its risk diversification strategy.

Competing companies

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Liquid Assets rapt.com|Company Cash Volume JBIO (Aerovate Therapeutics Inc)|Company Liquid Assets Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Cash Funds|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD